Skip to main content

Diaphragm Issues

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Synapse Biomedical
Synapse BiomedicalOH - Oberlin
1 program
NeuRx Diaphragm Pacing SystemN/A1 trial
Active Trials
NCT04457427Withdrawn0Est. Mar 2022
Stimit AG
Stimit AGSwitzerland - Biel
1 program
Stimit Activator 1N/A1 trial
Active Trials
NCT05883163Recruiting40Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Stimit AGStimit Activator 1
Synapse BiomedicalNeuRx Diaphragm Pacing System

Clinical Trials (2)

Total enrollment: 40 patients across 2 trials

NCT05883163Stimit AGStimit Activator 1

STIMIT Activator 1 IDE Study

Start: Jan 2024Est. completion: Jul 202640 patients
N/ARecruiting
NCT04457427Synapse BiomedicalNeuRx Diaphragm Pacing System

Randomized Study to Investigate the Safety and Performance of Diaphragm Stimulation Coupled With Mechanical Ventilation

Start: Dec 2016Est. completion: Mar 20220
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 40 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.